Antiviral Trio Shows Mettle Against COVID-19

FRIDAY, May 8, 2020 -- A triple whammy of three antiviral drugs shows promise in fighting mild to moderate COVID-19, a new, small study suggests. Two weeks of interferon beta-1b, lopinavir-ritonavir and ribavirin -- along with standard care -- was...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news